JP2014520117A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520117A5 JP2014520117A5 JP2014515342A JP2014515342A JP2014520117A5 JP 2014520117 A5 JP2014520117 A5 JP 2014520117A5 JP 2014515342 A JP2014515342 A JP 2014515342A JP 2014515342 A JP2014515342 A JP 2014515342A JP 2014520117 A5 JP2014520117 A5 JP 2014520117A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- chikungunya virus
- vaccine composition
- composition according
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2067CH2011 | 2011-06-17 | ||
| IN2067/CHE/2011 | 2011-06-17 | ||
| PCT/IN2012/000432 WO2012172574A1 (en) | 2011-06-17 | 2012-06-18 | Vaccine composition comprising an inactivated chikungunya virus strain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014520117A JP2014520117A (ja) | 2014-08-21 |
| JP2014520117A5 true JP2014520117A5 (https=) | 2015-07-16 |
| JP6147734B2 JP6147734B2 (ja) | 2017-06-14 |
Family
ID=46601866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014515342A Expired - Fee Related JP6147734B2 (ja) | 2011-06-17 | 2012-06-18 | 不活化チクングニアウイルス株を含むワクチン組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9844588B2 (https=) |
| EP (1) | EP2720715B1 (https=) |
| JP (1) | JP6147734B2 (https=) |
| KR (1) | KR101792684B1 (https=) |
| CN (1) | CN103796676B (https=) |
| AU (1) | AU2012269907B2 (https=) |
| BR (1) | BR112013032251B1 (https=) |
| MY (1) | MY173117A (https=) |
| PH (1) | PH12013502621A1 (https=) |
| SG (1) | SG10201607787RA (https=) |
| WO (1) | WO2012172574A1 (https=) |
| ZA (1) | ZA201309386B (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102181258B1 (ko) * | 2012-02-16 | 2020-11-20 | 브이엘피 테라퓨틱스 엘엘씨 | 바이러스 유사 입자 조성물 |
| TWI676636B (zh) | 2013-07-12 | 2019-11-11 | Ｖｌｐ醫療股份有限公司 | 包含ｐｄ－１抗原或ｐｄ－１配體抗原的類病毒粒子 |
| US10385101B2 (en) | 2014-08-08 | 2019-08-20 | Vlp Therapeutics, Llc | Virus like particle comprising modified envelope protein E3 |
| US9969986B2 (en) | 2014-08-08 | 2018-05-15 | Vlp Therapeutics, Llc | Virus like particle comprising modified envelope protein E3 |
| KR102532832B1 (ko) | 2014-09-11 | 2023-05-16 | 브이엘피 테라퓨틱스 인코포레이티드 | 플라비바이러스 바이러스 유사 입자 |
| EP3322441A4 (en) * | 2015-07-16 | 2018-12-19 | Bharat Biotech International Limited | Vaccine compositions |
| US20190054161A1 (en) * | 2016-01-13 | 2019-02-21 | United States, As Represented By The Secretary Of The Army | Inactivated vaccine for chikungunya virus |
| CN105906694B (zh) * | 2016-05-05 | 2019-05-14 | 中国人民解放军军事医学科学院微生物流行病研究所 | 基孔肯亚病毒特异性检测抗原及其应用 |
| US11090384B2 (en) | 2016-05-27 | 2021-08-17 | Griffith University | Arthrogenic alphavirus vaccine |
| KR101875055B1 (ko) * | 2016-10-19 | 2018-07-06 | 연세대학교 원주산학협력단 | 융합 단백질 및 그의 용도 |
| KR102007203B1 (ko) * | 2016-10-20 | 2019-08-05 | 연세대학교 원주산학협력단 | 융합 단백질 및 그의 용도 |
| WO2018074884A1 (ko) * | 2016-10-20 | 2018-04-26 | 연세대학교 원주산학협력단 | 재조합 단백질 및 그의 용도 |
| JP7301811B2 (ja) * | 2017-09-21 | 2023-07-03 | ヴァルネヴァ エスイー | 免疫原性チクングニアウイルスｃｈｉｋｖ－ｄｅｌｔａ ５ｎｓｐ３を含む医薬組成物を製造する方法 |
| KR20200117981A (ko) | 2017-11-03 | 2020-10-14 | 다케다 백신즈 인코포레이티드 | 지카 백신 및 면역원성 조성물, 그리고 이를 이용하는 방법들 |
| MX2020005554A (es) | 2017-11-30 | 2020-10-12 | Takeda Vaccines Inc | Vacunas y composiciones inmunogenas para zika y metodos para usarlas. |
| SG11202005792RA (en) | 2017-12-20 | 2020-07-29 | Vlp Therapeutics Llc | Alphavirus replicon particle |
| WO2019148086A1 (en) * | 2018-01-26 | 2019-08-01 | The Wistar Institute Of Anatomy And Biology | Vaccines against mosquito-borne viruses, and methods of using same |
| CN109536464B (zh) * | 2018-12-10 | 2022-06-10 | 中国科学院武汉病毒研究所 | 一种缺失衣壳蛋白基因的基孔肯雅病毒感染性克隆及构建方法和在制备减毒疫苗中的应用 |
| KR102016668B1 (ko) | 2018-12-19 | 2019-08-30 | 주식회사 엠디헬스케어 | 치쿤군야 바이러스 e2에 특이적으로 결합하는 dna 압타머 및 이의 용도 |
| US11562105B2 (en) * | 2019-07-11 | 2023-01-24 | Yokogawa Electric Corporation | System and method for module engineering with sequence libraries |
| KR102202082B1 (ko) | 2019-09-25 | 2021-01-11 | 충북대학교 산학협력단 | 치쿤군야 바이러스의 외피단백질 도메인 ⅱ에 대해 특이적으로 결합하는 단일클론항체, 이를 생산하는 하이브리도마 세포주 및 이의 용도 |
| TWI891771B (zh) | 2020-04-17 | 2025-08-01 | 美商Ｖｌｐ醫療股份有限公司 | 冠狀病毒疫苗 |
| AU2021264216A1 (en) | 2020-04-30 | 2022-11-10 | Vlp Therapeutics, Inc. | Cytokine immunotherapy |
| US20230398200A1 (en) * | 2020-07-31 | 2023-12-14 | Replicate Bioscience, Inc. | Modified chikungunya viruses and sindbis viruses and uses thereof |
| CN117771353B (zh) * | 2024-02-27 | 2024-05-14 | 中国医学科学院医学生物学研究所 | 一种以包膜蛋白为靶标的基孔肯雅病毒的mRNA疫苗及其制备方法 |
| CN118561969B (zh) * | 2024-08-02 | 2024-11-19 | 中国医学科学院医学生物学研究所 | 一种通过优化全长结构蛋白序列设计的基孔肯雅病毒广谱性mRNA疫苗 |
| KR102864666B1 (ko) * | 2025-04-21 | 2025-09-29 | 대한민국 | 치쿤구니아 바이러스 외피 재조합 dna를 포함하는 백신 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100233209A1 (en) | 2005-08-11 | 2010-09-16 | Higgs Stephen T | Chikungunya virus infectious clones and uses therefor |
| CN101516395B (zh) * | 2006-09-01 | 2014-03-26 | 伯哈拉特生物技术国际有限公司 | 抗屈曲病毒感染的疫苗 |
| JP2009149583A (ja) * | 2007-12-21 | 2009-07-09 | National Institute Of Biomedical Innovation | フラビウイルス感染症ワクチンおよびフラビウイルス感染症ワクチン用アジュバント |
| EP2370455B1 (en) | 2008-11-26 | 2019-07-03 | Government of the United States of America, as represented by the Secretary, Department of Health and Human Services | Virus like particle compositions and methods of use |
-
2012
- 2012-06-18 EP EP12741389.6A patent/EP2720715B1/en active Active
- 2012-06-18 AU AU2012269907A patent/AU2012269907B2/en not_active Ceased
- 2012-06-18 PH PH1/2013/502621A patent/PH12013502621A1/en unknown
- 2012-06-18 US US14/126,504 patent/US9844588B2/en active Active
- 2012-06-18 JP JP2014515342A patent/JP6147734B2/ja not_active Expired - Fee Related
- 2012-06-18 BR BR112013032251-9A patent/BR112013032251B1/pt not_active IP Right Cessation
- 2012-06-18 CN CN201280029793.9A patent/CN103796676B/zh active Active
- 2012-06-18 MY MYPI2013004491A patent/MY173117A/en unknown
- 2012-06-18 SG SG10201607787RA patent/SG10201607787RA/en unknown
- 2012-06-18 WO PCT/IN2012/000432 patent/WO2012172574A1/en not_active Ceased
- 2012-06-18 KR KR1020147000963A patent/KR101792684B1/ko active Active
-
2013
- 2013-12-12 ZA ZA2013/09386A patent/ZA201309386B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014520117A5 (https=) | ||
| US10022434B2 (en) | Influenza nucleic acid molecules and vaccines made therefrom | |
| US20160038584A1 (en) | Influenza Nucleic Acid Molecules And Vaccines Made Therefrom | |
| Stukova et al. | Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein | |
| US11123421B2 (en) | Cold adapted and virulence factor deleted live attenuated vaccine suitable for mucosal delivery | |
| JP5675789B2 (ja) | 免疫接種のための発現ベクターとしての水疱性口内炎ウイルスの異なる複数の抗原型 | |
| CA2835967A1 (en) | Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response | |
| Operschall et al. | Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice | |
| JP2019520090A (ja) | 弱毒変異型ジカウイルスを含むワクチン組成物 | |
| Hoover et al. | N-dihydrogalactochitosan serves as an effective mucosal adjuvant for intranasal vaccine in combination with recombinant viral proteins against respiratory infection | |
| JP7046848B2 (ja) | 弱毒化突然変異体ジカウイルスをコードするゲノム配列 | |
| JP7849046B2 (ja) | インフルエンザウイルスバックボーン | |
| Sarkar et al. | Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity | |
| KR102723171B1 (ko) | 신규한 코로나 바이러스의 에피토프 및 이의 용도 | |
| EP3708187A1 (en) | Single high dose of mva induces a protective immune response in neonates and infants | |
| TW202334404A (zh) | β冠狀病毒減毒株 | |
| JP4554268B2 (ja) | 分泌型ＩｇＡ抗体誘導剤 | |
| Chen | Influenza DNA vaccine: an update | |
| ES2557315T3 (es) | Nuevo virus de la gripe | |
| Martins et al. | Characterization of a putative filovirus vaccine: virus-like particles | |
| CN115925823A (zh) | SARS-CoV-2编码蛋白来源的T细胞表位多肽FAFPFTIYSL及其应用 | |
| Bohara et al. | Viral Vaccines | |
| ES2549366A1 (es) | TRIPLE MUTANTE DEL COMPLEJO MYCOBACTERIUM TUBERCULOSIS erp-, phoP- y DIM- | |
| Rajsri et al. | Efficacy of COVID-19 vaccines against the omicron variant of SARS-CoV-2 | |
| Attaran et al. | Immunogenicity and protective efficacy of recombinant M2e. Hsp70c (Hsp70359–610) fusion protein against influenza virus infection in mice |